Pregistry

Pregistry specializes in designing and executing large-scale observational studies and registries focused on drug and vaccine safety during pregnancy. It has led some of the world’s largest registries for COVID‑19 vaccines/treatments in pregnant populations. Its data supports regulatory commitments for pharmaceutical companies globally, including FDA/EMA mandates.

The company does not develop drugs but provides critical post-marketing surveillance and real-world evidence to inform prescribers, regulators, industry stakeholders, and patients.

Key recent clinical result includes launching the COVID‑19 International Drug Pregnancy Registry to assess obstetric/neonatal/infant outcomes following treatment for COVID‑19 during pregnancy.